That decision to stick with the CSL vaccine proved calamitous after it emerged that its molecular structure, which used elements of a protein from the HIV virus, meant that some patients in trials tested ‘false positive’ for HIV.
The premier of New South Wales, Gladys Berejiklian, conceded this week: ‘It’s spreading like we’ve never seen before.’ And yet there is a perfectly simple explanation – and it lies in Australia’s abject failure to establish a vaccine programme.Īustralian ministers initially focused solely on a homegrown product manufactured by the company CSL in cooperation with Queensland University and failed to secure millions of doses of other vaccines from around the world as back up (unlike Britain which, despite the early promise of the Oxford/AstraZeneca vaccine, ordered a range of Covid jabs). Indeed, the goal of ‘zero-Covid’ is more distant than ever. But this draconian approach isn’t working. Travel to and from local areas is curtailed in some cities, shops are closed, and public gatherings banned.Īt the weekend, 300 troops were deployed in the Sydney suburbs, door-to-door checking that those who have tested positive were self-isolating at home. The authorities’ answer has been to impose ever harsher measures in areas with the highest incidence of the disease, including New South Wales and Queensland. Australia is sliding into its own Covid crisis caused by the new, more transmissible Delta (formerly the ‘Indian’) variant. The other death was in a 44-year-old man.Pictured: Protesters are seen during the 'World Wide Rally For Freedom' anti-lockdown rally in Melbourne, Saturday, July 24, 2021īut now the ‘lucky country’ appears to have run short of luck. Four of the five deaths occurred in women aged 48 (two cases), 52 and 72-years-old. Cases meeting the criteria for Tier 1 were also twice as likely to occur in women compared to men. Nearly half of the TTS cases in women required treatment in intensive care. In Australia, severe cases of TTS appear to be more common in women in younger age groups.
These cases, which have presented with less serious symptoms will be considered by an external panel of experts in the coming week to determine whether they are related to vaccination or not.
We continue to investigate three probable TTS cases which appear to be related to the second dose. This takes the total Australian reports assessed as TTS following the AstraZeneca vaccine to 87 cases (53 confirmed, 34 probable) from approximately 6.1 million vaccine doses. All of them were related to a first dose of the vaccine. Since the beginning of the vaccine rollout in Australia, a total of five deaths from TTS have been reported out of 6.1 million doses of the AstraZeneca vaccine. The TGA extends its sincerest condolences to their families and loved ones. One was in a 44-year-old man from Tasmania and the other was in a 48-year-old women from Victoria (this case was reported as probable TTS in last week’s report). Sadly, this week we were notified that two confirmed cases of TTS after the first dose of the AstraZeneca vaccine were fatal. Here are some interesting slabs from the just released TGA Covid-19 vaccine weekly safety report about the rare blood clotting condition thrombocytopenia syndrome (TTS): 04.20 Five blood clotting deaths after 6.1m AZ doses, TGA says
0 kommentar(er)
